Stemline Therapeutics, a clinical stage biopharmaceutical company, and The Leukemia & Lymphoma Society (LLS), a voluntary health organization, have announced their collaboration to accelerate the development of SL-401 for the treatment of ...
Myriad Genetics, a US-based molecular diagnostic company, has launched a new prognostic test, Myriad myPlan Lung Cancer, for patients diagnosed with early-stage lung adenocarcinoma. myPlan lung cancer test is an RNA expression panel of 31 ...
US-based Loxo Oncology has announced that its lead clinical program is a potent and selective inhibitor of the Trk family of receptor tyrosine kinases. Loxo Oncology acquired rights to this program from Array Biopharma, which had pursued ...
Tags: Loxo Oncology, Medicine
KEW Group, the oncology personalized medicine management and analytics company, has launched CancerPlex assay, a comprehensive gene testing panel that can be used to examine the genetic profile of many common cancers. Developed and ...
Tags: Genomic Testing, Medicine
Senesco Technologies reported the treatment of the first patient at the Company’s newly opened clinical-trial site at Seattle Cancer Care Alliance (SCCA). This patient is part of Senesco’s Phase 1b/2a clinical study of its ...
Tags: Senesco, Clinical Trial
Medical device company Varian Medical Systems has obtained 510(k) approval from the US Food and Drug Administration for RapidPlan, a radiotherapy treatment planning tool designed to enhance quality, consistency, and efficiency in ...
Surefire Medical, a developer of infusion systems for the interventional radiology and interventional oncology markets, has introduced Surefire Infusion System mT, designed to treat vessels as small as 2–3.5mm in interventional ...
Foundation Medicine, molecular information company, has announced that results from a 24-month, multi-institution collaboration demonstrating the analytic validation of its cancer genomic profiling assay, FoundationOne, were published in ...
Tags: Foundation Medicine
US-based biotechnology firm that develops novel anticancer therapeutics using antibody-drug conjugate (ADC) technology, ImmunoGen (IMGN) has signed a licensing agreement with Novartis, pursuant to which, Novartis has the exclusive right to ...
Tags: Immunogen, Novartis, ADC Technology
Idaho-based Sockeye Brewing has partnered with CROWN Beverage Packaging North America, a business unit of Crown Holdings, Inc., to launch its flagship Dagger Falls IPA brand in limited-edition pink cans. Available in local stores ...
Sockeye Brewing and Crown Holdings' business unit CROWN Beverage Packaging North America has introduced Dagger Falls IPA beers in limited-edition pink color cans for cancer awareness. The new 12 oz cans, which will be available in ...
Tags: Sockeye Brewing, IPA Beers, Pink Cans
US-based MetaStat has announced that a study of 481 women with breast cancer has confirmed that the MetaSite Score (a count of the number of TMEM structures) was found to be associated with a statistically significant increase in the risk ...
Tags: MetaStat, Breast Cancer
Precision Spine, a spinal device company, has obtained 510(k) approval from the US Food and Drug Administration (FDA) for additional components of its Reform pedicle screw system, designed to treat spinal deformities. The additional ...
Cornerstone Pharmaceuticals has received the US Food and Drug Administration (FDA) orphan drug designation for its altered energy metabolism directed (AEMD) drug candidate 'CPI-613' for treatment of myelodysplastic syndrome (MDS). MDS is ...
Golden Biotechnology Corp. from Taiwan recently held a press conference in Beijing, launching Antroquinonol. Golden Biotechnology is a local leader in the Antrodia camphorate field, having put USD 100 million in research and development ...
Tags: Biotechnology, Health, Medicine